Recap of eAJKD’s coverage of the 2013 American Transplant Congress

Check out all of the coverage of this year’s American Transplant Congress by eAJKD’s Dr. Vinay Nair below:

• Alemtuzumab Induction and Belatacept-Based Immunosuppression in Kidney Transplant Recipients

• Eculizumab Therapy for Chronic Antibody Mediated Rejection

• The Impact of Pre-donation Weight Loss on Post-donation Outcome

• Does Adding Rituximab to IVIg and Plasmapheresis Improve Outcome of AMR? 1-Yr Results of RITUX-ERAH Study

• Everolimus in Liver Transplant Patients Preserves GFR. PROTECT Study – 35 Month Update

• Long-term Risk of ESRD in Kidney Donors – Is There Really No Harm?

• Development of De Novo HLA Antibodies After Transplantation – Results from the CTOT02 Study

• Simultaneous Liver Kidney Transplantation – Stealing or Saving?

• Everolimus in Kidney Transplantation – HERAKLES trial